Effect of Respiratory Versus Aerobic Training on Respiratory and Immunity Efficiency in Recovered COVID- 19 Patients

Cairo University (CU)

Status: Completed

Conditions: Covid 19 Infection

Treatments: Other: Respiratory Training; Other: Aerobic training

Study type: Interventional

Funder types: Other

Identifiers

NCT04613050

MAHA2020

Details and patient eligibility

About

This study will be conducted on eighty patients of both sexes with age ranging from 35 to 45years. The will be recovered from COVID-19 infection with chest symptoms. They will be selected from Nasr city police authority hospital. They will be randomly assigned into 3 equal groups.

Full description

This study will be conducted on eighty patients of both sexes with age ranging from 35 to 45years. The will be recovered from COVID-19 infection with chest symptoms. They will be selected from Nasr city police authority hospital. They will be randomly assigned into 3 equal groups.

Participants will be assigned into 3 groups equal in number (group A, group B, group C)

Group A (Respiratory Training Group) : It will include 30 patients of both sexes, recovered from COVID-19 infection. In addition to medical drugs, they will receive respiratory training for 6 weeks.

Group B : (Aerobic Training Group) : It will include 30 patients of both sexes, recovered from COVID-19 infection. In addition to medical drugs, they will receive aerobic training for 6 weeks

Group C : (control group) :It will include 20 patients of both sexes, recovered from COVID-19 infection on medical drugs only will receive no exercise as control group.

Enrollment: 80 patients

Sex: All

Ages: 35 to 45 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients recovered from COVID -19 infection.
• Patients with body mass index 25 - 35 kg/m2
• Patients previously diagnosed with chest symptoms of COVID- 19 infection.
• Patients' body temperature less than 37.5
• Blood oxygen saturation ≥95%

Exclusion criteria

• Smokers
• Patients with Myocardial infarction
• Patients with diabetes.
• Patients with autoimmune disease.
• Patients with positive COVID -19 infection.
• Patients with previous chest diseases
• a heart rate of >100 bpm
• a blood pressure of <90/60 mmHg or >140/90 mmHg
• a blood oxygen saturation of ≤95%
• other diseases that are not suitable for exercise (osteoarthritis knee - stroke patients, etc)

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

80 participants in 3 patient groups

Group A (Respiratory Training Group)

Active Comparator group

Description:

It will include 30 patients of both sexes, recovered from COVID-19 infection. In addition to medical drugs, they will receive respiratory training for 6 weeks.

Treatment:

Other: Respiratory Training

Group B : (Aerobic Training Group)

Active Comparator group

Description:

It will include 30 patients of both sexes, recovered from COVID-19 infection. In addition to medical drugs, they will receive aerobic training for 6 weeks

Treatment:

Other: Aerobic training

Group C : (control group)

No Intervention group

Description:

It will include 20 patients of both sexes, recovered from COVID-19 infection on medical drugs only will receive no exercise as control group.